0001398344-14-001101.txt : 20140214 0001398344-14-001101.hdr.sgml : 20140214 20140214171121 ACCESSION NUMBER: 0001398344-14-001101 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140214 DATE AS OF CHANGE: 20140214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60603 FILM NUMBER: 14619044 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Central Square Management LLC CENTRAL INDEX KEY: 0001441559 IRS NUMBER: 331163626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1813 N. MILL STREET STREET 2: SUITE F CITY: NAPERVILLE STATE: IL ZIP: 60563 BUSINESS PHONE: 630-210-8924 MAIL ADDRESS: STREET 1: 1813 N. MILL STREET STREET 2: SUITE F CITY: NAPERVILLE STATE: IL ZIP: 60563 FORMER COMPANY: FORMER CONFORMED NAME: Central Square Management, LLC DATE OF NAME CHANGE: 20080730 SC 13G/A 1 fp0009642_sc13ga.htm HARVARD BIOSCIENCE, INC. fp0009642_sc13ga.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB APPROVAL
OMB Number:3235-0145
Expires: February 28, 2009
Estimated average burden
hours per response… 10.4
 

SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
 
(Amendment No.  4)
 
HARVARD BIOSCIENCE, INC.
(Name of Issuer)

Common Stock, par value $0.01 per share
(Title of Class of Securities)

 
416906105
 
(CUSIP Number)

December 31, 2013
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[ ]           Rule 13d-1(b)
 
[x]          Rule 13d-1(c)
 
[ ]           Rule 13d-1(d)
 

*           The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.  Beneficial ownership information contained herein is given as of the date listed above.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 

 
 
CUSIP No. 416906105
13G
Page 2 of 8
 
1
Names of Reporting Persons.
Central Square Management LLC
I.R.S. Identification Nos. of above persons (entities only)
2
Check the Appropriate Box if a Member of a Group (See Instructions)
 
(a)           [ ]
 
(b)           [ ]
3
SEC Use Only
4
Citizenship or Place of Organization.
Central Square Management LLC - Delaware
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
5    Sole Voting Power
Central Square Management LLC - 0 shares
6    Shared Voting Power
Central Square Management LLC -  128,973 shares
Refer to Item 4 below.
7    Sole Dispositive Power
Central Square Management LLC - 0 shares
8    Shared Dispositive Power
Central Square Management LLC – 128,973 shares
Refer to Item 4 below.
9
Aggregate Amount Beneficially Owned by Each Reporting Person
Central Square Management LLC – 128,973 shares
Refer to Item 4 below.
10
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)     [ ]
Not applicable.
11
Percent of Class Represented by Amount in Row (9)
Central Square Management LLC – 0.4%
Refer to Item 4 below.
12
Type of Reporting Person (See Instructions)
Central Square Management LLC - OO (Limited Liability Company)

 
 

 
 
CUSIP No. 416906105
13G
Page 3 of 8
 
1
Names of Reporting Persons.
Kelly Cardwell
I.R.S. Identification Nos. of above persons (entities only)
2
Check the Appropriate Box if a Member of a Group (See Instructions)
 
(a)           [ ]
 
(b)           [ ]
3
SEC Use Only
4
Citizenship or Place of Organization.
Kelly Cardwell – United States
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
5    Sole Voting Power
Kelly Cardwell- 0 shares
6    Shared Voting Power
Kelly Cardwell – 128,973 shares
Refer to Item 4 below.
7    Sole Dispositive Power
Kelly Cardwell - 0 shares
8    Shared Dispositive Power
Kelly Cardwell – 128,973 shares
Refer to Item 4 below.
9
Aggregate Amount Beneficially Owned by Each Reporting Person
Kelly Cardwell  – 128,973 shares
Refer to Item 4 below.
10
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)     [ ]
Not applicable.
11
Percent of Class Represented by Amount in Row (9)
Kelly Cardwell – 0.4%
Refer to Item 4 below.
12
Type of Reporting Person (See Instructions)
Kelly Cardwell- IN

 
 

 
 
CUSIP No. 416906105
13G
Page 4 of 8
 
Item 1.
 
 
(a)
Name of Issuer
   
Harvard Bioscience, Inc.
 
(b)
Address of Issuer’s Principal Executive Offices
   
84 October Hill Road, Holliston, MA 01746

Item 2.
 
 
(a)
Name of Person Filing
   
Central Square Management LLC
Kelly Cardwell
 
(b)
Address of Principal Business Office or, if none, Residence
   
Central Square Management LLC
Kelly Cardwell
1813 N. Mill Street
Suite F
Naperville, IL
60563
 
(c)
Citizenship
   
Central Square Management LLC - Delaware
Kelly Cardwell - United States
 
(d)
Title of Class of Securities
   
Common Stock, par value $0.01 per share
 
(e)
CUSIP Number
   
416906105

Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
 
(a)
[ ]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
 
(b)
[ ]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
 
(c)
[ ]
Insurance Company as defined in Section 3(a)(19) of the Act;
 
(d)
[ ]
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
 
(e)
[X]
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
 
(f)
[ ]
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
 
(g)
[ ]
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
 
 
 

 
 
CUSIP No. 416906105
13G
Page 5 of 8
 
 
(h)
[ ]
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
(i)
[ ]
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
 
(j)
[ ]
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
 
(k)
[ ]
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
 
 If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
 
Item 4.
Ownership**
 
 Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
 
(a)
Amount Beneficially Owned **
   
Central Square Management LLC – 128,973 shares
Kelly Cardwell - 128,973 shares
 
(b)
Percent of Class**
   
Central Square Management LLC  – 0.4%
Kelly Cardwell – 0.4%
 
(c)
Number of shares as to which such person has:
   
(i)
sole power to vote or to direct the vote **
     
Central Square Management LLC - 0 shares
Kelly Cardwell - 0 shares
   
(ii)
shared power to vote or to direct the vote**
     
Central Square Management LLC – 128,973 shares
Kelly Cardwell - 128,973 shares
   
(iii)
sole power to dispose or to direct the disposition of**
     
Central Square Management LLC - 0 shares
Kelly Cardwell - 0 shares
   
(iv)
shared power to dispose or to direct the disposition of**
     
Central Square Management LLC – 128,973 shares
Kelly Cardwell - 128,973 shares

**
Shares reported herein for Central Square Management LLC (“CSM LLC”) represent shares which are beneficially owned by certain private investment funds (the “Funds”), for which CSM LLC serves as investment manager and for which affiliates of CSM LLC serve as the general partner.  Shares reported herein for Mr. Cardwell represent the above referenced shares beneficially owned by the Funds.  Mr. Cardwell serves as the manager of CSM LLC, as well as the manager of each of the general partners of the Funds.  Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.
 
 
 

 
 
CUSIP No. 416906105
13G
Page 6 of 8
 
Item 5.
Ownership of Five Percent or Less of a Class
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].
 
Not applicable.
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person
 
Not applicable.
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
 
Not applicable.
 
Item 8.
Identification and Classification of Members of the Group
 
Not applicable.
 
Item 9.
Notice of Dissolution of Group
 
Not applicable.
 
Item 10.
Certification
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 

 
 
CUSIP No. 416906105
13G
Page 7 of 8
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date:
February 14, 2014
 
 
CENTRAL SQUARE MANAGEMENT LLC
   
 
By:
/s/ Kelly Cardwell
 
   
Kelly Cardwell
 
   
Manager
 
       
 
KELLY CARDWELL
   
 
/s/ Kelly Cardwell
 
 
Kelly Cardwell, individually
 

 
 

 
 
CUSIP No. 416906105
13G
Page 8 of 8
 
Exhibit 1
 
JOINT FILING AGREEMENT
 
This Joint Filing Agreement, dated as of February 14, 2011, is by and among Central Square Management LLC and Kelly Cardwell, an individual (the foregoing are collectively referred to herein as the “Filers”).
 
Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13G with respect to shares of Common Stock, par value $0.01 per share, of Harvard Bioscience, Inc. beneficially owned by them from time to time.
 
Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13G and/or 13D (and any amendments thereto) on behalf of each of such parties, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.
 
This Joint Filing Agreement may be terminated by any of the Filers upon one week’s prior written notice or such lesser period of notice as the Filers may mutually agree.
 
Executed and delivered as of the date first above written.
 
 
CENTRAL SQUARE MANAGEMENT LLC
   
 
By:
/s/ Kelly Cardwell
 
   
Kelly Cardwell
 
   
Manager
 
       
 
KELLY CARDWELL
 
     
 
/s/ Kelly Cardwell
 
 
Kelly Cardwell, individually